4 completed. .
Follow Astellas Pharma S.A.S.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients Fidaxomicin, Treatment for CDI other than fidaxomicin Type - Clostridium Difficile Infection | Completed | Astellas Pharma S.A.S. | 296 | 2014-09-03 | 2017-10-12 | |
| A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®) Tacrolimus - Renal Transplantation | Completed | Astellas Pharma S.A.S. | 578 | 2014-07-17 | 2024-11-01 | |
| Use of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematology Micafungin - Antifungal Prophylaxis, Haemopathy | Completed | Astellas Pharma S.A.S. | 150 | 2014-07-03 | 2024-10-21 | |
| A Multicenter Study in Liver Transplant Patients Converted From Prograf® to Advagraf® During the First Post-transplantation Year Tacrolimus - Liver Transplantation | Completed | Astellas Pharma S.A.S. | 398 | 2014-06-18 | 2024-10-21 |
Clostridium Infections (1) · Invasive Fungal Infections (1)
Tacrolimus (2) · Fidaxomicin (1) · Micafungin (1) · Therapeutics (1)
France (4)